The U.S. Food & Drug Administration has been introducing manufacturing control practices that encourage pharmaceutical makers to move away from empirical standards. One example of this push for quantified process monitoring is crystallization, a process crucial in drug production. A Bruker Optics white paper describes how this can be done scientifically using a MATRIX-F spectrometer.
